Skip to main content

Table 1 Sillence classification system for osteogenesis imperfecta

From: Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta

OI Type

Features

Type I

Mildest form. Limited bone deformity and fragility.

Type II

Lethal in perinatal period.

Type III

Most severe form in patients who survive the newborn period.

Type IV

Moderate severity. Spectrum of severity between types I and III.

Additional OI types

Range in severity. Etiology is typically due to mutations in genes involved with collagen formation other than COL1A1 or COL1A2.